Thamiris Dias Delfino Cabral

Thamiris Dias Delfino Cabral

Auto-generated profile, based on publicly available information

Thamiris Dias Delfino Cabral

Department of Otolaryngology Federal Hospital of Bonsucesso Rio de Janeiro Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2023 in Journal of Chest Surgery
Verified
Journal Article
Open access
PDF file
PVPatricia Viana
Patricia Viana
JRJessica Hoffmann Relvas
Jessica Hoffmann Relvas
MPMarina Persson
Marina Persson
TCThamiris Dias Delfino Cabral
Thamiris Dias Delfino Cabral
JPJorge Eduardo Persson
Jorge Eduardo Persson
SASara Amaral
Sara Amaral
Patricia Viana, Jessica Hoffmann Relvas, M.D., Marina Persson, M.D., Thamiris Dias Delfino Cabral, M.D., Jorge Eduardo Persson, Jessica Sales de Oliveira, Paulo Bonow, M.D., Camila Veronica Souza Freire, M.D., Sara Amaral, M.D.. J Chest Surg 2024;57:25-35. https://doi.org/10.5090/jcs.23.081

30 January 2025 in Artificial Organs
Verified
Journal Article
Closed access
PVPatricia Viana
Patricia Viana
SCSamy Castillo‐Flores
Samy Castillo‐Flores
MMMaria M. R. Mora
Maria M. R. Mora
TCThamiris D. D. Cabral
Thamiris D. D. Cabral
PMPaulo N. Martins
Paulo N. Martins
IFIsabella Faria
Isabella Faria

9 May 2024 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
PVPatricia Viana
Patricia Viana
JRJessica Hoffmann Relvas
Jessica Hoffmann Relvas
TCThamiris Dias Delfino Cabral
Thamiris Dias Delfino Cabral
JPJorge Eduardo Persson
Jorge Eduardo Persson
AAArtur Menegaz de Almeida
Artur Menegaz de Almeida
Jamary Oliveira FilhoJamary Oliveira Filho
Jamary Oliveira Filho

15 August 2025 in The Laryngoscope
Verified
Journal Article
Closed access
TCThamiris D. D. Cabral
Thamiris D. D. Cabral
RKRenata M. Knoll
Renata M. Knoll
JPJaime Plane
Jaime Plane
PVPatricia Viana
Patricia Viana
BVBruno Dalla Vecchia Vendramini
Bruno Dalla Vecchia Vendramini
PHPhillip Huyett
Phillip Huyett

11 April 2026 in Clinics
Verified
Journal Article
Open access
Anna Luíza Soares de Oliveira RodriguesAnna Luíza Soares de Oliveira Rodrigues
Anna Luíza Soares de Oliveira Rodrigues
FRFlavio Pola dos Reis
Flavio Pola dos Reis
TCThamiris Dias Delfino Cabral
Thamiris Dias Delfino Cabral
SSSamuel Lucas Dos Santos
Samuel Lucas Dos Santos
LFLucas Matos Fernandes
Lucas Matos Fernandes
PPPaulo Manuel Pêgo-Fernandes
Paulo Manuel Pêgo-Fernandes
Organ preservation at low temperatures has been described since Alexis Carrel's time in 1912. Since then, organs have been stored in a mixture of frozen saline solution and liquid, with a temperature of around 4 °C. Studies suggest higher temperatures may preserve mitochondrial function, allowing for an extended ischemia time. Various systems are commercially available, each with different preservation principles. This study aims to analyze the underlying parameters of each device. A systematic review was conducted using the following databases: PubMed, Embase, and Cochrane Library, searching for clinical trials and observational studies evaluating the use of thermal boxes for lung preservation devices in transplantation. The assessed outcomes were Primary Graft Dysfunction (PGD), ventilation time, length of hospital stay, rejection rate, and survival rate. The search yielded six studies selected based on title and abstract, including 519 lung transplant cases. The preservation systems evaluated were LUNGguard and MYTEMPF. Our studies assessed LUNGguard, with a total of 298 patients. This system maintained an average temperature of 6 °C (4° to 8 °C), and 51 patients developed grade 3 PGD within 72 h. The mean ventilation time was 25.2 h (25 to 25.5 h), and ICU stay ranged from 8 to 9 days. Rejection was observed in 3 out of 18 patients, and hospital survival was reported in 221 out of 231 patients. MYTEMP 65 HC was evaluated in one study with 70 patients, of whom 4 developed grade 3 PGD within 72 h. The mean ventilation time was 49 h, and the length of hospital stay was 25 days. Kaplan-Meier estimated survival was 94 % (HR = 0.65; 95 % CI 0.26 to 1.6). Preservation systems show different performances in lung preservation devices for transplantation. Across available studies, LUNGguard has been reported to maintain temperature stability with corresponding survival findings. Across studies of MYTEMP, lower grade 3 PGD rates have been reported, together with longer ventilation and hospitalization durations, and the device is described as non-transport. Other devices exist on the market, but their data remains unpublished. In summary, ongoing clinical studies with these and other preservation devices are expected to provide new evidence in the near future. As additional data become available, an updated systematic review will help clarify their comparative performance and guide clinical practice.

12 July 2023
Verified
Report
Closed access
LPLucas Carvalho Pereira
Lucas Carvalho Pereira
IPIgor Carvalho Pereira
Igor Carvalho Pereira
TCThamiris Dias Delfino Cabral
Thamiris Dias Delfino Cabral
PVPatricia Mendes Viana
Patricia Mendes Viana
INPLASY202370047 Balanced crystalloids versus normal saline in kidney transplant: an updated systematic review and meta-analysis Keywords: balanced crystalloids; low-chloride solutions; normal sali…